With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...

Novavax, Inc. recently announced at the Jefferies London Healthcare Conference 2025 that it is shifting its focus from direct COVID-19 commercial operations to an expanded research and development ...

Novavax, Inc. (NVAX) reported a 3Q25 EPS loss and declining revenue, but beat revenue expectations and reaffirmed its FY25 ...

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, and Vaxart, Inc. (OTCQX: VXRT), a clinical-stage ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to ...

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...

The U.S. Food and Drug Administration will now require COVID-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition ...

NEW YORK CITY -- Americans may need to get a single COVID-19 vaccination every year, federal health officials said Tuesday, making clear that the country will be living with the coronavirus for the ...

Most Americans with health insurance should not have to pay out of pocket for Covid-19 vaccines, even after the US Centers for Disease Control and Prevention added an extra hurdle to getting the shot.